Bioleaders Corporation (142760) — Cash Flow Quality Index
Bioleaders Corporation (142760) has a Cash Flow Quality Index of 21.06x as of June 2024. Operating cash flow of ₩19.27 Billion exceeds net income of ₩914.71 Million, indicating high earnings quality where cash backs reported profits. Explore Bioleaders Corporation long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bioleaders Corporation Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Bioleaders Corporation across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 142760 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Bioleaders Corporation (2023–2023)
Year-by-year earnings quality comparison for Bioleaders Corporation. For live market cap and the full company financial profile, see 142760 market cap.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.76x | ₩6.18 Billion | ₩8.07 Billion | — |